• Organizer
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA
  Roger Narayan
  (UNC/NCSU Joint Department of Biomedical Engineering, USA)

  Dr. Roger Narayan is a Distinguished Professor in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University. He is an author of over two hundred publications as well as several book chapters on the processing, characterization, and modeling of biomedical materials. He currently serves as an editorial board member for several academic journals, including as associate editor of Applied Physics Reviews (AIP Publishing). Dr. Narayan has received several honors for his research activities, including the University of North Carolina Jefferson-Pilot Fellowship in Academic Medicine and the American Ceramic Society Richard M. Fulrath Award. He has been elected as a Fellow of the American Ceramic Society, ASM International, AAAS, ASME, AIMBE, and the Materials Research Society.
• Chair
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA

  Roger Narayan
  (UNC/NCSU Joint Department of Biomedical Engineering, USA)

  Dr. Roger Narayan is a Distinguished Professor in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University. He is an author of over two hundred publications as well as several book chapters on the processing, characterization, and modeling of biomedical materials. He currently serves as an editorial board member for several academic journals, including as associate editor of Applied Physics Reviews (AIP Publishing). Dr. Narayan has received several honors for his research activities, including the University of North Carolina Jefferson-Pilot Fellowship in Academic Medicine and the American Ceramic Society Richard M. Fulrath Award. He has been elected as a Fellow of the American Ceramic Society, ASM International, AAAS, ASME, AIMBE, and the Materials Research Society.
• Co-chair
  Jinah Jang
  Pohang University of Science and Technology, Korea, Republic of
• Speaker
  13:00~13:30
  Wei Sun
  Drexel University and Tsinghua University, China
  Presentation Title : Innovations in Bioprinting and Biofabrication Technologies

  Wei Sun
  (Drexel University and Tsinghua University, China)

  Dr. Sun Wei, a young researcher at State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University. He obtained his Ph.D. from Tongji University in 2019 under the supervision of Professor Wu Guangming. He joined Donghua University in October 2019 and his main research areas include the design and construction of functional conductive elastic materials, and 3D printing of biomaterials for medical applications. He has published a total of 25 SCI papers, with 15 papers as the first author/corresponding author in international academic journals such as ACS Nano, Theranostics, J. Mater. Chem. A, Adv. Electron. Mater., etc. One of his papers has been highly cited according to ESI. He has filed 7 invention patents in China, 5 of which have been granted. He is the principal investigator for 1 National Natural Science Foundation of China (NSFC) Young Scientist Fund, 2 sub-projects of the Ministry of Science and Technology's key research and development program, and 1 collaborative project with industry.
• Speaker
  13:30~14:00
  James Yoo
  Wake Forest Institute for Regenerative Medicine, USA
  Presentation Title : Novel Materials for Regenerative Medicine
• Speaker
  14:00~14:30
  Jinah Jang
  Pohang University of Science and Technology, Korea, Republic of
  Presentation Title : Translational Studies Involving 3D Printing and Bioprinting Technologies
• Speaker
  14:30~15:00
  Roger Narayan
  UNC/NCSU Joint Department of Biomedical Engineering, USA
  Presentation Title : Innovations in Photopolymerization-based 3D Printing and Bioprinting Technologies

  Roger Narayan
  (UNC/NCSU Joint Department of Biomedical Engineering, USA)

  Dr. Roger Narayan is a Distinguished Professor in the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University. He is an author of over two hundred publications as well as several book chapters on the processing, characterization, and modeling of biomedical materials. He currently serves as an editorial board member for several academic journals, including as associate editor of Applied Physics Reviews (AIP Publishing). Dr. Narayan has received several honors for his research activities, including the University of North Carolina Jefferson-Pilot Fellowship in Academic Medicine and the American Ceramic Society Richard M. Fulrath Award. He has been elected as a Fellow of the American Ceramic Society, ASM International, AAAS, ASME, AIMBE, and the Materials Research Society.
• Speaker
  15:00~15:30
  Jinye Wang
  Shanghai Jiao Tong University, China
  Presentation Title : A Water-responsive 4D Printing Ink Derived from Maize Protein Zein

  Jinye Wang
  (Shanghai Jiao Tong University, China)

  Prof. Jin-Ye Wang, Ph.D (Tohoku University, Japan, 1992). Professor of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (2000-2009); Professor of Biomedical Engineering, Shanghai Jiao Tong University (2009-). Published 140 papers and 6 books (chapters); authorized 20 patents; invited speaker of European Conference on Biomaterials, Pacifichem et al.; awarded Hundred Talent Program of the Chinese Academy of Sciences (1999), Life Sciences Prize from Meiji Dairies Corporation (2008) et al. Research interests: 3D Bioprinting, Tissue Engineering, Controlled Release, Biomimetic Materials and Biointerfaces. Selected Publications (2020-)： 1. Lin, Y.F., Yu, J.W., Zhang, Y.B., Hayat, H., Liu, C., Huang, X.Y., Lin, H.D.* and Wang, J.Y.* 4D Printed Tri-segment Nerve Conduit Using Zein Gel as the Ink for Repair of Rat Sciatic Nerve Large Defect. (2023) Biomaterial Advance, 151, 213473. 10.1016/j.bioadv.2023.213473 2. Hayat, H., Liu, C., Raza, A., Jingli Hou, J., Jia, C. and Wang, J.Y.* In vitro/in vivo identification of zein degraded peptides using HPLC-MS/MS and their safety evaluation. (2023) Biomedical Materials, 18, 025007. https://iopscience.iop.org/article/10.1088/1748-605X/acb411 3. Zhang,Y., Xue, Y., Ogawa, T., Wada, S. and Wang, J.Y.* 3D Printed Alginate Hydrogels with Stiffness-Gradient Structure in a Carbomer Supporting Bath by Controlled Ca2+ Diffusion. (2023) ACS Applied Engineering Materials, 1, 802-812. https://pubs.acs.org/doi/10.1021/acsaenm.2c00218 4. Jia, C.W., Zhang, Y.C., Wang, Y.Y., Gao, J.N., Raza, A., Ogawa, T., Wada, S., Xie, D. and Wang, J.Y.* Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficacy assessment of tumor metastases to lungs. (2023) Journal of Drug Delivery Science and Technology, 80, 104081. https://www.sciencedirect.com/science/article/pii/S1773224722009923 5. Zhang, Y.B., Raza, A., Xue, Y.Q., Yang, G.G., Hayat, U., Yu, J.W., Liu, C., Wang, H.J. and Wang, J.Y.* Water-responsive 4D printing based on self-assembly of hydrophobic protein “Zein” for the control of degradation rate and drug release. (2023) Bioactive Materials, 23, 343-352. 6. Raza, A., Zhang, Y.B., Uzma, H., Song, J.L., Shen, N.A., Chao, Y., Wang, H.J.* and Wang, J.Y.* Injectable zein gel with in situ self-assembly as hemostatic material. (2023) Biomaterial Advance, 145, 213225. 7. Xue, Y.Q., Zhang, Y.C., Zhang, Y.B. and Wang, J.Y.* Zein-based 3D Vascularized Scaffolds with Tunable Porosity for 3D Cell Culture and Drug Delivery. (2023) Biomedical Engineering Advances,5, 100059. https://www.sciencedirect.com/science/article/pii/S2667099222000354 8. Raza, A., Uzma, H., Zhang, X.H. and Wang, J.Y.* Self-assembled zein organogels as in situ forming implant drug delivery system and 3D printing ink. (2022) International Journal of Pharmaceutics, 627, 122206. 9. Li, J., Zhou, Y., Xu, J., Gao, F., Si, Q., Wang, J.Y., Zhang, F. and Wang, L.P.* Water-Soluble and Degradable Gelatin/Polyaniline Assemblies with High Photothermal Conversion Efficiency for pH Switchable Precise Photothermal Therapy. （2022）ACS Applied Materials & Interfaces, 14, 52670-52683. 10. Liu, C., Uzma, H., Raza, A., Jia, C.W. and Wang, J.Y.* Zein-based injectable biomaterial and angiogenic activity through peptides produced by enzymatic degradation. (2022) Journal of Drug Delivery Science and Technology, 78, 103937. 11. Zhang, Y.B., Wang, H.J., Raza, A., Liu, C., Yu, J.W. and and Wang, J.Y.* Preparation and evaluation of chitosan/polyvinylpyrrolidone/zein composite hemostatic sponges. (2022) International Journal of Biological Macromolecules. 205, 110-117. 12. Uzma, H., Raza, A., Bilal, M.N. lqbal, H.M.N* and Wang, J.Y.* Biodegradable polymeric conduits: Platform materials for guided nerve regeneration and vascular tissue engineering. (2022) Journal of Drug Delivery Science and Technology, 67, 103014. 13. Liu, C., Yang, H., Shen, N.A., Li, J.H., Chen, Y.S. and Wang, J.Y.* Improvement of Mechanical Properties of Zein Porous Scaffold by Quenching/Electrospun Fiber Reinforcement. (2021) Biomedical Materials, 16, 065016. 14. Wang, H.J.*, Mao, Q.Y., Feng, G., Liu, C., Yang, M.Z., Hao, M.F., Meng, Z.F., Li, S.M., Zhang, Y.P. and Wang, J.Y.* 3D printing of multi-functional artificial conduits against acute thrombosis and clinical infection. (2022) Composites Part B-Engineering, 230, 109497. 15. Yu, J.W., Wang, G.W., Lin, Y.F., Song, J.L., Hayat, U., Liu, C., Raza, A., Wu, W.F., Lin, H.D. and Wang, J.Y.* Zein-induced immune response and modulation by size, pore structure and drug-loading: Application for sciatic nerve regeneration. (2022) Acta Biomaterialia, 140, 289-301. 16. Wang, L.P., Wang, H.J., Hou, X.S., Raza A. and Wang, J.Y.* Preparation of stretchable composite film and its application in skin burn repair. (2021) Journal of the Mechanical Behavior of Biomedical Materials, 113, 104114. 17. Shen, N.A., Zhang, Y. and Wang, J.Y.* A parallel plate flow chamber device for evaluation of cell retention of electrospun zein fiber film under steady shear. (2021) Journal of Shanghai Jiaotong University (Sci), 26 (1), 69-75. 18. Shen, N.A., Zhang, Y. and Wang, J.Y.* Effects of the micro/nanostructure of electrospun zein fibres on cells in a fluid environment. (2021) Materials Science and Engineering C, 122, 111900. 19. Hou X.S., Zhou Y., Liu Y.J., Wang L.P.*, Wang J.Y. Coaxial electrospun flexible PANI//PU fibers as highly sensitive pH wearable sensor. (2020) Journal of Material Science, 55(33), 16033-16047. 20. Raza, A., Uzma, H., Bilal, M., lqbal, H.M.N* and Wang, J.Y.* Zein-based micro- and nano- constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. (2020) Journal of Drug Delivery Science and Technology, 58, 101818. 21. Uzma, H, Raza, A. and Wang, J.Y.* Preparation of Zein/PVP based conduits with tunable degradation. (2020) Polymer Degradation and Stability, 181, 109303. 22. Raza, A., Uzma, H., Wang, H.J. and Wang, J.Y.* Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets. (2020) International Journal of Pharmaceutics, 579, 119185. 23. Uzma, H., Raza, A., Wang, H.J.* and Wang, J.Y.* Preparation of ciprofloxacin loaded zein conduits with good mechanical properties and antibacterial activity. (2020) Materials Science and Engineering C, 111, 110766.

Industrial and academic researchers have recently examined the use of 3D printing and bioprinting technologies to overcome the limitations associated with conventional biomedical manufacturing processes. These technologies involve the processing of biomaterials into three-dimensional structures through the joining of materials in a layer-by-layer manner. This workshop will review recent developments in 3D printing and bioprinting technologies for processing biomaterials into artificial tissues as well as biosensors, drug delivery devices, and medical instruments. Several topics related to 3D printing and bioprinting, including the development of appropriate computer models, novel 3D printing and bioprinting technologies, and novel materials for use in 3D printing and bioprinting, will be discussed. This workshop will create collaboration among the many groups involved in the development and use of 3D printing and bioprinting technologies, including biomaterials scientists, medical device manufacturers, and clinicians. We anticipate that this workshop will facilitate future research activities, including industry-university collaborations, involving 3D printing and bioprinting of biomaterials for use in medicine, surgery, and dentistry. 
The target audience will include: 
- university-, government-, and industry-based biomaterial engineers
- medical scientists
- medical device manufacturers
- equipment manufacturers
- regulatory officials and administrators
- clinicians

• Organizer
  Bingyun Li
  West Virginia University School of Medicine, USA
  Bingyun Li
  (West Virginia University School of Medicine, USA)

  Dr. Bingyun Li is a full Professor in the Department of Orthopaedics at West Virginia University (USA). He is a member of the Society for Biomaterials (SFB), Materials Research Society (MRS), Orthopaedic Research Society (ORS), American Society for Microbiology (ASM), Chinese Association for Biomaterials (CAB), and International Chinese Musculoskeletal Research Society (ICMRS). Currently, Dr. Li is serving as the President of CAB and Liaison Committee Chair of SFB. Dr. Li is a fellow of the American Institute for Medical and Biological Engineering (AIMBE). Dr. Li’s research focuses on advanced materials, bioengineering, and nanomedicine. He has supervised 100+ trainees, and his research group has published 112 peer-reviewed articles (h-index=53), four edited books, 11 book chapters, 12 provisional/full patents, and 178 abstracts. Dr. Li has given 67 invited talks including three keynote presentations at national and international conferences.
• Chair
  Jian Yang
  Westlake University, China

  Jian Yang
  (Westlake University, China)

  Dr. Jian Yang is currently a Chair Professor in Biomaterials and Regenerative Engineering, the chair of Biomedical Engineering Program, and an Associate Vice President at the Westlake University. Prior to Westlake, he was a Professor of Biomedical Engineering and Dorothy Foehr Huck and J. Lloyd Huck Chair in Regenerative Engineering at the Pennsylvania State University. Dr. Yang is known for his pioneering contribution on citrate chemistry and biology for the development and applications of citrate-based biomaterials. He was a recipient of NSF CAREER Award (2010), Outstanding Young Engineering Faculty Award at UTA (2011), PSEAS Outstanding Research Award at Penn State (2018), and BMES Wallace H. Coulter Award for Healthcare Innovation Award (2023). Dr. Yang is an elected Fellow of American Institute of Medical and Biological Engineering (AIMBE, 2016), the National Academy of Inventors (NAI, 2018), the Biomedical Engineering Society (BMES, 2020), the American Association for the Advancement of Science (AAAS, 2021), and the International Academy of Medical and Biological Engineering (IAMBE, 2023). Dr. Yang is the Co-Editor-in-Chief of “Bioactive Materials”, and an Associate Editor of “Science Advances”. Dr. Yang is a co-founder and the Past-President of Chinese Association for Biomaterials (CAB) and the recipient of 2023 CAB Distinguished Leadership and Service Award. Dr. Yang co-founded a medical device company, Aleo BME, Inc. and is also serving on the Scientific Advisory Board of Acuitive Technologies, LLC.
• Co-chair
  Kelvin Yeung
  The University of Hong Kong, Hong Kong SAR, China

  Kelvin Yeung
  (The University of Hong Kong, Hong Kong SAR, China)

  Professor Kelvin Yeung is a renowned expert in orthopaedic biomaterial research, with a primary focus on the design of orthopaedic biomaterials, antibacterial nano-materials, 3D bio-printing, and musculoskeletal tissue engineering. He obtained his bachelor's degree in materials science and further pursued a master's degree and PhD in orthopaedic science at the University of Hong Kong's Medical Faculty. Over the years, he has concentrated on bone-to-implant osseointegration, bone regeneration, and antibacterial treatments. Currently, Professor Yeung serves as a tenured full professor, chief of the research division, and departmental research and postgraduate advisor in the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine (HKUMed), at The University of Hong Kong. Additionally, he has received honorary appointments as a professor in the Department of Orthopaedics at Zhongshan Hospital and as a researcher in the Institute of Spinal Tumour at Fudan University. His impressive h-index (Scopus) is 80, with over 21,000 citations and 88 (Google Scholar) with 25,000+ citations and an i10-index of 263. He has been recognized as one of the Highly Cited Researchers 2023 (cross-field), ranking among the Top 1% Scholars Worldwide in the field of biomaterials by Clarivate Analytics' Essential Science Indicators (ESI) and among the World's Top 2% Scientists in standardized citation indicators (Biomedical Engineering) since 2014. In 2024, he ranked #1845 globally and #483 in China under the category of materials science (Research.com). Beyond his extensive publication record, which includes over 300 peer-reviewed SCI journal papers and 43 filed full patents in various countries, Professor Yeung co-founded OrthoSmart Limited with two senior colleagues to translate their research findings into clinical applications. He also serves as a consultant for several Hong Kong-listed medical and biomaterials corporations.
• Speaker
  16:00~16:35
  William Wagner
  University of Pittsburgh, USA
  Presentation Title : Developing biomaterials and scaffolds to meet distinct clinical needs

  William Wagner
  (University of Pittsburgh, USA)

  Professor William R. Wagner is a Distinguished Professor of Surgery, Chemical Engineering, and Bioengineering at the University of Pittsburgh and the Founding Editor and Editor-in-Chief of one of the leading biomaterials journals, Acta Biomaterialia. He holds a B.S. (Johns Hopkins Univ.) and Ph.D. (Univ. of Texas) in chemical engineering. Professor Wagner currently serves as president of the Society for Biomaterials (US) and is a past-president of the American Society for Artificial Internal Organs (ASAIO) and past chairman of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Americas region. He is a fellow and former vice president of the American Institute for Medical and Biological Engineering (AIMBE) and has also been elected a fellow of the Biomedical Engineering Society, the International Union of Societies for Biomaterials Science and Engineering, TERMIS, the International Academy of Medical and Biological Engineering (IAMBE) and the American Heart Association. He has been selected to the “Scientific American 50”, the magazine’s annual list recognizing leaders in science and technology from the research, business and policy fields. His research has generated numerous patents (50 issued to date) and patent filings that have resulted in licensing activity, the formation of three companies, one of which initiated two clinical trials. Transfer of his group’s intellectual property has been recognized with University of Pittsburgh Innovator Awards in 2007, 2008, 2009, 2010, 2014, 2017 and 2018. Some of his awards include the Society for Biomaterials Clemson Award for Applied Research, the Chancellor’s Distinguished Research Award from the University of Pittsburgh, and the Senior Investigator Award from TERMIS-Americas. In 2017 he was inducted as a fellow of the National Academy of Inventors and in 2018 he was named Inventor of the Year by the Pittsburgh Intellectual Property Law Association. In 2019 Dr. Wagner was promoted to the rank of Distinguished Professor, the highest recognition available to University of Pittsburgh faculty. In 2020 the 4th edition of the best-selling biomaterials textbook, “Biomaterials Science” was published with Dr. Wagner taking over the lead editor role and in partnership with a new generation editorial team. He was also named by Pittsburgh Business Times to its “Power 100” list (“people who have defined and are redefining the region, and who are leading and shaping their industries”). Dr. Wagner recently received the Founder’s Award from the Society for Biomaterials (2021) and the Global Biomaterials Leadership Award from the Chinese Association for Biomaterials (2023). Dr. Wagner also was recently awarded the Marlin Mickle Outstanding Innovator Award through the University of Pittsburgh’s Innovation Institute for extraordinary commitment to innovation commercialization. Dr. Wagner’s research interests are in cardiovascular engineering with projects that address medical device biocompatibility and design, biomaterial development, and tissue engineering.
• Speaker
  16:35~17:10
  Guillermo Ameer
  Northwestern University, USA
  Presentation Title : Regenerative Biomaterials and medical devices: A new hope

  Guillermo Ameer
  (Northwestern University, USA)

  Dr. Ameer is the Daniel Hale Williams professor of Biomedical Engineering and Surgery at Northwestern University. He is the founding director of the Center for Advanced Regenerative Engineering (CARE), director of the NIH-funded Regenerative Engineering Training Program (RE-Training), and Deputy Editor at Science Advances, a journal published by the American Association for the Advancement of Science (AAAS). He is a member of the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences. Dr. Ameer’s laboratory pioneered the development and tissue regeneration applications of citrate-based biomaterials, the core technology behind innovative bioresorbable orthopaedic tissue fixation devices CITRELOCK,TM CITREFIX,TM CITRESPLINE,TM CITRELOCK ACL,TM and CITRELOCK DUOTM which were recently cleared by the F.D.A for clinical use. His awards include the Key to the City of Panama, the Society for Biomaterials (SFB) Clemson Award for Contributions to the Literature, the SFB Technology Innovation and Development Award, the Tissue Engineering and Regenerative Medicine International Society-Americas the Surfaces in Biomaterials Foundation Excellence in Biomaterials Science Award, the Chinese Association for Biomaterials Global Biomaterials Leadership Award, the Bioactive Materials Lifetime Achievement Award, and the Biomedical Engineering Society Athanasiou Medal for Excellence in Translational Bioengineering. He is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), Fellow of the Biomedical Engineering Society, Fellow of the AIChE, Fellow of the American Association for the Advancement of Science, and Fellow of the Materials Research Society. In addition to his deputy editor role at Science Advances, Dr. Ameer is an Associate Editor for the Regenerative Engineering and Translational Medicine journal, a member of the board of directors of the Regenerative Engineering Society, and past chair of the AIMBE College of Fellows.
• Speaker
  17:10~17:45
  Xuesi Chen
  University of Chinese Academy of Sciences, China
  Presentation Title : Biodegrade polymers and their biomedical applications
• Speaker
  17:45~18:20
  Shaoyi Jiang
  Cornell University, USA
  Presentation Title : Biomaterials beyond poly(ethylene glycol)

  Shaoyi Jiang
  (Cornell University, USA)

  Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials, particularly highly biocompatible and environmentally benign zwitterionic-based materials for biomedical and engineering applications.

Innovative biomaterial research and development have greatly improved the health and economy worldwide. The objective of this workshop is to host the biomaterial leaders to discuss the key elements en route to successful biomaterial technology translation with the participation of academic researchers, investors, industrial leaders, scientists, and students. The outcome is to a platform where biomaterial excellence finds its exit to technology translation and a networking opportunity to mingle with academic and industrial leaders in biomaterials. This workshop is relevant to the WBC topics including Biomaterials for industrial applications, Biomaterials enabling technologies, Biomaterials for pre-clinical and clinical translation, and Biomaterials for tissue engineering.

• Organizer
  Xing-Jie Liang
  National Center for Nanoscience and Technology of China, China
  Xing-Jie Liang
  (National Center for Nanoscience and Technology of China, China)

  Xing-Jie LIANG, Ph.D.
  Member of Academia Europaea
  Fellow of American Institute of Medical and Biological Engineering
  Chief Professor, University of Chinese Academy of Sciences
  CAS Center for Excellence in Nanoscience
  CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety
  National Center for Nanoscience and Technology of China
  E-mail： liangxj@nanoctr.cn
  Tel: +86-010-82545569 Fax: +86-010-62656765
  ORCID: 0000-0002-4793-1705
  
  
  Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials.
  
  His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.
• Chair
  Xing-Jie Liang
  National Center for Nanoscience and Technology of China, China

  Xing-Jie Liang
  (National Center for Nanoscience and Technology of China, China)

  Xing-Jie LIANG, Ph.D. Member of Academia Europaea Fellow of American Institute of Medical and Biological Engineering Chief Professor, University of Chinese Academy of Sciences CAS Center for Excellence in Nanoscience CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology of China E-mail： liangxj@nanoctr.cn Tel: +86-010-82545569 Fax: +86-010-62656765 ORCID: 0000-0002-4793-1705 Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials. His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.
• Co-chair
  Bingyang Shi
  Henan University, China
• Speaker
  16:30~17:00
  Kam Leong
  Columbia University, USA
  Presentation Title : Immunological modulation of Biomaterials
• Speaker
  17:00~17:25
  Juyong Yoon
  Ewha Womans University, Korea, Republic of

  Juyong Yoon
  (Ewha Womans University, Korea, Republic of)

  Juyoung Yoon is a distinguished professor at the Department of Chemistry and Nanoscience, Ewha Womans University. He received his PhD (1994) from Ohio State University and conducted his postdoctoral work at UCLA and Scripps Research Institute. His research interests include investigations of fluorescent imaging probes, activatable photosensitizers, phototherapy and organic functional materials. His h-index is 124 and was listed as a highly cited researcher in chemistry for 2014-2023.
• Speaker
  17:25~17:50
  Guixue Wang
  Bioengineering College of Chongqing University, China

  Guixue Wang
  (Bioengineering College of Chongqing University, China)

  Dr. Guixue Wang is a Distinguished Professor of Biomedical Engineering and former Dean of the College of Bioengineering, Chongqing University, China. He also worked as the Principal Investigator of JinFeng Laboratory at Chongqing. He has also served as a Deputy Director of the Academic Committee of Chongqing University Health Science Center. He is a director of the Key Laboratory of Biorheology Science and Technology of the Chinese Ministry of Education, a founding director of the Public Experiment Center of National Biological Industrialization Base at Chongqing, and a founding director of the National Local Joint Engineering Laboratory for Vascular Implants of China, a founding director of Chongqing Engineering Laboratory for Vascular Implants of China. He serves as an Associate Editor of Research (IF:11), Deputy Editor-in-Chief of Molecular & Cellular Biomechanics, an Associate Editor of Journal of Medical and Biological Engineering, and an Editorial Member of Biomedical Materials. He also serves as a reviewer for 50 international journals. He has served as multiple Chairpersons: including Branch of Atherosclerosis of the Chinese Society of Pathophysiology (2021.05-) and Materiobiomechanics Branch of the Chinese Society for Biomaterials (2022.12-), Honorary Chairperson: Vascular Branch of the Chinese Society of Anatomy (2023.12-), Executive Member of the Council: Interventional Treatment of Cardiac and Brain Diseases Branch of the Chinese Medical Device Industry Association (2017-), Cardiovascular Biomaterials Branch of the Chinese Society for Biomaterials (2015-), Chinese Branch of International Society of Atherosclerosis (2015-), Holistic Integrative Medicine and Engineering Alliance (2018-); Member of the Council: Chinese Society of Biomedical Engineering (2015-1019), Chinese Society for Biomaterials (2012-), Biomechanics Branch of the Chinese Society of Mechanics/Chinese Society of Biomedical Engineering (2015-), and Life Member: including World Association for Chinese Biomedical Engineers (2016-) and International Chinese Musculoskeletal Research Society (2019-). His areas of research interest include vascular biomechanics and mechanobiology, tissue repair materials and minimally invasive interventional medical devices. He has led more than 20 national and provincial-level key scientific research projects; collaboratively published more than 300 SCI/EI indexed papers in Nat Neurosci, J Biomech, Adv Sci, Bioact Mater, Biomaterials and other academic journals; authorized more than 60 domestic and international patents; and won 6 provincial and ministerial science and technology and teaching achievement awards, 3 national industry associations and societies awards. He was selected as the Elsevier “Most Cited Chinese Researchers in Biomedical Engineering” in 2019, 2020, 2021, 2022 and 2023; World's Top 2% Scientists in 2023; and a Fellow of International Union of Societies for Biomaterials Science and Engineering (FBSE) in 2023.
• Speaker
  17:50~18:15
  Hyung-Jun Im
  Seoul National University, Korea, Republic of

  Hyung-Jun Im
  (Seoul National University, Korea, Republic of)

  Dr Hyung-Jun Im, MD, Ph.D., is an Associate Professor at the Graduate School of Convergence Science and Technology, Seoul National University, Republic of Korea. Dr. Im earned his MD degree from the School of Medicine at The Catholic University of Korea in 2007 and underwent residency and fellowship training in Nuclear Medicine at Seoul National University Hospital. He also earned a Ph.D. degree from the Department of Molecular Medicine and Biopharmaceutical Sciences at Seoul National University in 2015 and completed two years of post-doctoral training in the Department of Radiology at the University of Wisconsin-Madison. Dr. Im conducts leading research in the fields of nuclear medicine, nanomedicine, and theranostics. He has authored 89 research papers in these fields (H-index = 35), including works in Nature Biomedical Engineering, Journal of Nuclear Medicine, Radiology, ACS Nano and Theranostics. Dr. Im has been an active member of the Young Korean Academy of Science and Technology (Y-KAST) since 2022. He is currently serving as the associate editor of the Journal of Nanobiotechnology and as the Editor-in-Chief of Health Nanotechnology.
• Speaker
  18:15~18:40
  Dong Ma
  Jinan University, China

  Dong Ma
  (Jinan University, China)

  Prof. Ma Dong is currently a researcher and doctoral supervisor at the Institute of Biomedical Engineering, Jinan University. He studied for a doctoral degree at the School of Chemistry and Chemical Engineering, Sun Yat-sen University from 2005 to 2010, and then is engaged in postdoctoral research at the Postdoctoral Station of Materials Physics and Chemistry of Sun Yat-sen University. From June 2012 to present, he has served as a lecturer, associate professor (2013), and professor (2018) at the Institute of Biomedical Engineering, Jinan University. He has been engaged in the research of biomedical polymer materials. He has published more than 50 SCI papers, authorized more than 10 Chinese invention patents, of which 2 were transferred. He has won 2 second prizes in Guangdong Provincial Science and Technology Awards, the 2021 China Biotechnology Conference Excellent Patent Award, the 2022 7th China Innovation Challenge (Guangzhou, Guangdong) Excellence Award, etc.; has been selected as the Guangzhou Pearl River Science and Technology Rising Star, and the Guangdong Province Outstanding Young Teacher Training plan, etc. He is currently the director of the Institute of Biomedical Engineering of Jinan University and a director of the Guangdong Biomedical Engineering Society.

Objectives or purposes
Explore a better future with advanced science and technology
Proposed program and target audience
Include at least 4-5 wellknown scientists in the biomateials field, they have very excellent reputation and scientific credits internationally on the immunological regulation of biomaterials applied in clinic as scarfold. The targeted audiences are suitable for undergraduates or graduates and earlier careers of pricinpal investigators who are interested in the multiple functions of biocompatible materials applied in vivo for replacement of tissue or efficient treatment of maglinent tumors.
Expected outcomes and relevance to the main topic of WBC 2024
Wish this workshop as platform to attract more students and young scientists who are involved in the biomaterials practical transition for clinical applications, the audences will receive broader overview on the immunoligical outcome of Biomaterials how it works efficiently in vivo by a novel pathway. It will construct straight bridge to tight with main topic of WBC 2024 and broader the coverage of conference with additional mechanism and scientific direction of biomaterials.